ConductScience.org, home

Paper346153

Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?

Maurice-Williams RS. Br Med J, 1978. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Papers, record 346153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/346153

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
PubMed
Journal
Br Med J
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
4
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maurice-Williams RSR S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Intracranial AneurysmMajor topic
Tranexamic AcidMajor topic
Clinical Trials as Topic
Humans
Recurrence
Rupture, Spontaneous
Subarachnoid Hemorrhage

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114107926MULTIPLE INTRACRANIAL ANEURYSMS.Lancet1964https://conductscience.org/library/papers/14107926PubMed
2963461Intracranial aneurysms: analysis of results of microneurosurgery.Br Med J1976https://conductscience.org/library/papers/963461PubMed
34127547Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay.Lancet1973https://conductscience.org/library/papers/4127547PubMed
44138300Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.Lancet1974https://conductscience.org/library/papers/4138300PubMed
54830928Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.Med J Aust1974https://conductscience.org/library/papers/4830928PubMed
65026538Preoperative management of patients with ruptured intracranial aneurysms.J Neurosurg1972https://conductscience.org/library/papers/5026538PubMed
75570768Results of a controlled trial of late surgical versus conservative treatment of intracranial arterial aneurysms.J Neurosurg1971https://conductscience.org/library/papers/5570768PubMed
85790480The use of antifibrinolytic substances in ruptured intracranial aneurysms.Neurochirurgia (Stuttg)1969https://conductscience.org/library/papers/5790480PubMed
94268202Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.J Neurosurg1973https://conductscience.org/library/papers/4268202PubMed
105639737Antifibrinolytic therapy for intracranial aneurysms.J Neurosurg1968https://conductscience.org/library/papers/5639737PubMed
115921326Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.J Neurosurg1966https://conductscience.org/library/papers/5921326PubMed
121255236Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms.J Neurosurg1976https://conductscience.org/library/papers/1255236PubMed
131185218Proceedings: Anterior communicating artery aneurysms.J Neurol Neurosurg Psychiatry1975https://conductscience.org/library/papers/1185218PubMed
141185216Results of surgical treatment of pericallosal aneurysms.J Neurol Neurosurg Psychiatry1975https://conductscience.org/library/papers/1185216PubMed
151198627Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.Stroke1975https://conductscience.org/library/papers/1198627PubMed
164231539Comparative studies of fibrinolytic inhibitors in vitro.Thromb Diath Haemorrh1966https://conductscience.org/library/papers/4231539PubMed
17936974Echo-encephalographic study of ventricular dilatation after subarachnoid hemorrhage, with special reference to the effect of antifibrinolytic treatment.Acta Neurol Scand1976https://conductscience.org/library/papers/936974PubMed
185547318The effect of epsilon aminocaproic acid and tranexamic acid on thrombus size and strength in a simulated arterial aneurysm.J Neurosurg1971https://conductscience.org/library/papers/5547318PubMed

Download CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
42095754
European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage.
Eur Stroke J2026https://conductscience.org/library/papers/42095754PubMed
40599738Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis.Front Neurol2025https://conductscience.org/library/papers/40599738PubMed
40316838Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events.CNS Drugs2025https://conductscience.org/library/papers/40316838PubMed
37228855The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Future Sci OA2023https://conductscience.org/library/papers/37228855PubMed
37000863Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis.PLoS One2023https://conductscience.org/library/papers/37000863PubMed
36350005Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36350005PubMed
35140671Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.Front Neurol2021https://conductscience.org/library/papers/35140671PubMed
35083272Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Surg2021https://conductscience.org/library/papers/35083272PubMed
34677620Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.Intensive Care Med2021https://conductscience.org/library/papers/34677620PubMed
34315966Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis.Sci Rep2021https://conductscience.org/library/papers/34315966PubMed
33851983Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression.JAMA Surg2021https://conductscience.org/library/papers/33851983PubMed
31360727Evaluation of Vascular Endothelial Growth Factor A and Selected Parameters of Coagulation and Fibrinolysis in a Group of Patients with Subarachnoid Haemorrhage.Biomed Res Int2019https://conductscience.org/library/papers/31360727PubMed
30741383Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review.CNS Drugs2019https://conductscience.org/library/papers/30741383PubMed
23990381Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23990381PubMed
21761274Rebleeding after aneurysmal subarachnoid hemorrhage.Neurocrit Care2011https://conductscience.org/library/papers/21761274PubMed
18386187Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.Neurocrit Care2008https://conductscience.org/library/papers/18386187PubMed
10400410Tranexamic acid: a review of its use in surgery and other indications.Drugs1999https://conductscience.org/library/papers/10400410PubMed
9854979Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage.J Neurol Neurosurg Psychiatry1998https://conductscience.org/library/papers/9854979PubMed
7435290Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7435290PubMed
7359154Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7359154PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/346153

GET https://conductscience.org/api/papers/v1/346153/cited_by?page=2